![]() Roar Biomedical Roar Biomedical is a company that supports drug discovery and clinical research by bringing technologies to market. | ![]() Aurobindo Pharma Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa. | ![]() Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations. | Nexelis Nexelis is an immunology centric provider offering preclinical and clinical specialty laboratory services. | |
Founding Date | Founding Date 1997 | Founding Date 1986 | Founding Date 1977 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public | Type Private |
Tags | ||||
Locations | Locations New York, US HQ | Locations Hyderabad, IN HQ Hyderabad, IN South Brunswick Township, US | Locations Mumbai, IN HQ Mumbai, IN | Locations Laval, CA HQ Charleroi, BE Beijing, CN Marburg, DE Salisbury, GB Indianapolis, US Seattle, US |
Employees | Employees 2 | Employees 26,015 | Employees 14,989 | Employees 1802% decrease |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₹333.8b (FY, 2026) | Revenue (est.) ₹167.1b (FY, 2026) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ₹134.9b (FY, 2026) | Cost of goods ₹47.5b (FY, 2026) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ₹206.6b (FY, 2026) | Gross profit ₹127b (FY, 2026) | Gross profit N/A |
Net income | Net income N/A | Net income ₹35b (FY, 2026) | Net income ₹13.6b (FY, 2026) | Net income N/A |

Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa.
View company
Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations.
View companyNexelis is an immunology centric provider offering preclinical and clinical specialty laboratory services.
View company